AVEO Pharmaceuticals Inc (NASDAQ:AVEO) - Share price - Overview

Stock Report

AVEO Pharmaceuticals Inc AVEO

Last Price
$2.22

Day Change
-0.06|-2.63%

As of 25/05/2018
16:25:50 EDT | USD
Minimum 15 Minutes Delay.

Last Close2.28
Day Range2.19 - 2.30
Mkt Cap263.90Mil
52-Wk Range0.63 - 4.24
Yield %-
ISINUS0535881090
Volume880,932
P/E-3.89
P/S43.48
P/CF-13.01

Share Price

Financials
201520162017
More ...
Income Statement
Revenue19.022.527.58
Operating Income-8.07-29.39-26.74
Net Income-15.00-26.89-65.03
Basic EPS-0.27-0.39-0.61
Avg. Diluted Shares Outstanding5669106
Balance Sheet
Current Assets40.3826.3250.18
Non Current Assets0.170.970.02
Total Assets40.5427.2950.20
Current Liabilities12.4010.3532.12
Total Liabilities---
Total Equity17.23-1.92-40.76
Cash Flow
Operating Cash Flow-18.23-31.07-19.16
Capital Expenditure-0.02-0.01-
Free Cash Flow-18.25-31.07-

In millions, except "Basic EPS". Currency is USD.

Company Profile

AVEO Pharmaceuticals Inc is a biopharmaceutical company focused on discovering, developing and commercializing novel cancer therapeutics. The firm offers products such as Tivozanib, Ficlatuzmab, AV-203, AV-380, and AV-353.

Sector

Healthcare

Industry

Biotechnology

Stock Style

Small-Value

Fiscal Year Ends

December

Employees

19
Key Stats
More ...
Price/Earning TTM-4.00
Price/Book-5.39
Price/Sales TTM35.57
Rev Growth (3 year avg)-25.22
EPS Growth (3 year avg)-
Operating Margin % TTM-352.79
Net Margin % TTM-857.96
ROE TTM-
Debt/Equity-
Dividends
PreviousLatest
More ...
Declared Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.